BR112012020252B8 - processo para a preparação de nebivolol - Google Patents

processo para a preparação de nebivolol

Info

Publication number
BR112012020252B8
BR112012020252B8 BR112012020252A BR112012020252A BR112012020252B8 BR 112012020252 B8 BR112012020252 B8 BR 112012020252B8 BR 112012020252 A BR112012020252 A BR 112012020252A BR 112012020252 A BR112012020252 A BR 112012020252A BR 112012020252 B8 BR112012020252 B8 BR 112012020252B8
Authority
BR
Brazil
Prior art keywords
nebivolol
preparing nebivolol
preparing
synthesis
allowing
Prior art date
Application number
BR112012020252A
Other languages
English (en)
Other versions
BR112012020252A2 (pt
BR112012020252B1 (pt
Inventor
Cipollone Amalia
Fattori Daniela
Bartoli Sandra
Original Assignee
Menarini Int Operations Luxembourg Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Luxembourg Sa filed Critical Menarini Int Operations Luxembourg Sa
Publication of BR112012020252A2 publication Critical patent/BR112012020252A2/pt
Publication of BR112012020252B1 publication Critical patent/BR112012020252B1/pt
Publication of BR112012020252B8 publication Critical patent/BR112012020252B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treating Waste Gases (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Peptides Or Proteins (AREA)

Abstract

processo para a preparação de nebivolol. a presente invenção está relacionada a um novo processo para a síntese de produto de nebivolol representado no esquema (1), que compreende um número reduzido de etapas de alto rendimento, e caracterizado pela resolução cinética dos dois pares de epóxido diastereoisoméricos entre eles (mistura 1), permitindo evitar separações cromatográficas complexas.
BR112012020252A 2010-02-11 2011-02-09 processo para a preparação de nebivolol BR112012020252B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2010A000053 2010-02-11
ITRM2010A000053A IT1397962B1 (it) 2010-02-11 2010-02-11 Processo per la preparazione del nebivololo.
PCT/EP2011/051876 WO2011098474A1 (en) 2010-02-11 2011-02-09 Process for the preparation of nebivolol

Publications (3)

Publication Number Publication Date
BR112012020252A2 BR112012020252A2 (pt) 2016-08-09
BR112012020252B1 BR112012020252B1 (pt) 2021-05-04
BR112012020252B8 true BR112012020252B8 (pt) 2021-05-25

Family

ID=42289104

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012020252A BR112012020252B8 (pt) 2010-02-11 2011-02-09 processo para a preparação de nebivolol

Country Status (22)

Country Link
US (1) US8487122B2 (pt)
EP (1) EP2534142B1 (pt)
JP (1) JP5698266B2 (pt)
KR (1) KR101726468B1 (pt)
CN (1) CN102858759B (pt)
AR (1) AR080149A1 (pt)
AU (1) AU2011214396B2 (pt)
BR (1) BR112012020252B8 (pt)
CA (1) CA2786833C (pt)
EA (1) EA019691B1 (pt)
ES (1) ES2445543T3 (pt)
HK (1) HK1179626A1 (pt)
HR (1) HRP20140155T1 (pt)
IL (1) IL220846A (pt)
IT (1) IT1397962B1 (pt)
MX (1) MX2012009386A (pt)
PL (1) PL2534142T3 (pt)
PT (1) PT2534142E (pt)
RS (1) RS53134B (pt)
SG (1) SG183266A1 (pt)
WO (1) WO2011098474A1 (pt)
ZA (1) ZA201206221B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8785664B2 (en) 2010-02-11 2014-07-22 Menarini International Operations Luxembourg S.A. Process for the preparation of nebivolol
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
CN104650022B (zh) * 2013-11-20 2018-09-25 浙江奥翔药业股份有限公司 奈必洛尔的合成方法及其中间体化合物
MX354930B (es) * 2014-10-23 2018-03-20 Consorcio Comex S A De C V Composicion para aerosol usada para marcar o delimitar en cualquier tipo de superficie con una duracion temporal.
JP6921913B2 (ja) * 2015-05-19 2021-08-18 チョーチアン オウスン ファーマシューティカル カンパニー リミテッド ネビボロールの合成方法及びその中間化合物
PL3299364T3 (pl) 2015-05-19 2022-02-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Sposób syntezy nebiwololu i jego związek pośredni
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
ITUB20160227A1 (it) * 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475298A1 (fr) * 1980-02-01 1981-08-07 Thomson Csf Cellule photovoltaique et pile solaire utilisant une telle cellule
US4654362A (en) 1983-12-05 1987-03-31 Janssen Pharmaceutica, N.V. Derivatives of 2,2'-iminobisethanol
CA1337429C (en) 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
US6545040B1 (en) 1988-03-23 2003-04-08 Janssen Pharmaceutica N.V. Method of lowering the blood pressure
DE3809857A1 (de) 1988-03-24 1989-10-05 Philips Patentverwaltung Blasformmaschine zum blasformen von hohlkoerpern mit polsterregelung
TW355683B (en) 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
HU227236B1 (en) * 2002-11-06 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag New process for the production of racemic and the pure [2s[2r*[r[r*]]]]-and [2r[2s*[s[s*]]]]-enantiomers of nebivolol
CN101862322A (zh) * 2004-07-30 2010-10-20 托伦特药物有限公司 奈必洛尔及其药学可接受盐、制备方法以及奈必洛尔的药物组合物
UA87155C2 (ru) 2004-08-13 2009-06-25 Хардор Меканизм Продакшн Лтд Машина для обёртывание профилей
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
WO2007041805A1 (en) 2005-10-13 2007-04-19 Burns Bay Investments Pty Ltd Elongate lighting means
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
EP1973895A1 (en) 2006-01-18 2008-10-01 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
BRPI0719281B8 (pt) 2006-11-27 2021-05-25 Fis Fabbrica Italiana Sintetici Spa processo para preparação de nebivolol
WO2008064826A1 (en) 2006-11-27 2008-06-05 Zach System S.P.A. Process for preparing nebivolol
CN101235024A (zh) * 2008-02-01 2008-08-06 中国科学院上海有机化学研究所 一类苯并二氢吡喃类化合物、合成方法和用途

Also Published As

Publication number Publication date
HRP20140155T1 (hr) 2014-03-14
CN102858759A (zh) 2013-01-02
AU2011214396B2 (en) 2014-06-05
PT2534142E (pt) 2014-02-24
RS53134B (en) 2014-06-30
MX2012009386A (es) 2012-09-12
US8487122B2 (en) 2013-07-16
CA2786833A1 (en) 2011-08-18
KR20120129952A (ko) 2012-11-28
BR112012020252A2 (pt) 2016-08-09
EA019691B1 (ru) 2014-05-30
PL2534142T3 (pl) 2014-05-30
EP2534142B1 (en) 2013-11-27
AR080149A1 (es) 2012-03-14
IL220846A0 (en) 2012-08-30
JP2013519647A (ja) 2013-05-30
BR112012020252B1 (pt) 2021-05-04
EP2534142A1 (en) 2012-12-19
IL220846A (en) 2014-12-31
US20120316351A1 (en) 2012-12-13
IT1397962B1 (it) 2013-02-04
SG183266A1 (en) 2012-09-27
ZA201206221B (en) 2014-01-29
KR101726468B1 (ko) 2017-04-12
CN102858759B (zh) 2015-12-16
ES2445543T3 (es) 2014-03-03
ITRM20100053A1 (it) 2011-08-12
JP5698266B2 (ja) 2015-04-08
AU2011214396A1 (en) 2012-10-04
CA2786833C (en) 2017-03-07
WO2011098474A1 (en) 2011-08-18
EA201201127A1 (ru) 2013-01-30
HK1179626A1 (en) 2013-10-04

Similar Documents

Publication Publication Date Title
BR112012020252B8 (pt) processo para a preparação de nebivolol
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
UY31611A1 (es) Compuestos que comprenden un grupo ciclobutoxi
BR112015006874A2 (pt) ligantes de rig-i inovadores e métodos para produzir os mesmos
BR112012028395A2 (pt) processo para preparar ditiina-tetracarboxi-diimidas
ECSP13012958A (es) Inhibidores de benzodioxano de la producción de leucotrieno.
UA116991C2 (uk) Способи синтезу аматоксинового структурного елемента та аматоксинів
BR112014013098A2 (pt) composições compreendendo ácidos graxos que têm 20 carbonos e métodos de produção e uso dos mesmos
BR112014008550A2 (pt) citramida rasagilina
MX347882B (es) Procedimiento mejorado para preparar (3e, 7e)-homofarnesol.
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
CR20120287A (es) Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112013016863A2 (pt) processo para produzir um polistereterol
BR112015014583B1 (pt) compostos, processo para a preparação de compostos, compostos intermediários, composição, usos de um composto de fórmula i e método para combater fungos nocivos
UY31871A (es) Compuestos que comprenden un grupo ciclobutoxi
IN2014MN00976A (pt)
MX2013005930A (es) Proceso para la preparacion de nebivolol.
EA201291096A1 (ru) Финголимод в форме твердого раствора
MX2015005981A (es) Preparacion de intermediarios de agentes de contraste de rayos x.
BR112013020212A2 (pt) método de produção de um adoçante natuarl aprimorado
MX2014012796A (es) Procedimiento para preparar n-(5-cloro-2-isopropilbencil) ciclopropanamina.
MX354719B (es) Preparacion de una composicion que comprende microburbujas de gas.
SA515370303B1 (ar) جسيم سيليكا معدلة
BR112013001862A2 (pt) formulações
BR112013004546A2 (pt) processo para produção de tmhq.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 311/58

Ipc: C07D 311/58 (2006.01), C07D 311/04 (2006.01), A61P

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/02/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/02/2011 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF